Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...
Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...
Alignment with National Health Security Goals: GeoVax’s focus on U.S.-based vaccine production supports HHS’s priority of reducing dependency on foreign pharmaceutical supply chains, ensuring ...
So far 70 confirmed human cases of H5N1 infection have been reported, following a widespread outbreak across bird and cattle ...
HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback